GenMont Biotech Incorporation (TPE:3164)
Taiwan · Delayed Price · Currency is TWD 18.05
+0.05 (0.28%)
Jan 22, 2026, 10:19 AM CST
TPE:3164 Revenue
GenMont Biotech Incorporation had revenue of 88.90M TWD in the quarter ending September 30, 2025, with 6.06% growth. This brings the company's revenue in the last twelve months to 391.48M, up 6.23% year-over-year. In the year 2024, GenMont Biotech Incorporation had annual revenue of 385.37M with 21.18% growth.
Revenue (ttm)
391.48M
Revenue Growth
+6.23%
P/S Ratio
3.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 385.37M | 67.36M | 21.18% |
| Dec 31, 2023 | 318.02M | -50.53M | -13.71% |
| Dec 31, 2022 | 368.55M | -59.38M | -13.88% |
| Dec 31, 2021 | 427.93M | 102.74M | 31.59% |
| Dec 31, 2020 | 325.19M | -21.05M | -6.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |
| Caliway Biopharmaceuticals | 34.99M |